CMR Surgical is a global medical devices company dedicated to transforming surgery with its next-generation surgical robotic system, Versius. Founded in 2014 and headquartered in Cambridge, United Kingdom, the company develops versatile, modular, and portable surgical robots designed to make minimal access surgery universally accessible and affordable for hospitals and surgeons across various clinical specialties, including general surgery, colorectal surgery, urology, gynecology, and thoracic surgery.

Its flagship platform, the Versius Surgical Robotic System (and the enhanced Versius Plus), features independent, compact modular arms that biomimic the human arm and provide fully articulated instruments with 3DHD vision and an open surgeon console. The platform is supported by an integrated digital ecosystem including Versius Connect and Versius Team apps for procedural logs and live performance tracking. Having achieved significant global commercial adoption across dozens of countries, the system has been utilized in tens of thousands of surgical procedures worldwide.

The company has raised significant venture capital and strategic funding from investors such as SoftBank, Ally Bridge Group, Tencent, and Cambridge Innovation Capital, alongside debt financing from Trinity Capital. In late 2026, CMR Surgical announced a major strategic alliance and preferred equity investment by Stryker, positioning Stryker as the exclusive U.S. sales agent for the Versius portfolio with an option for future acquisition.